Samsung Biologics, AstraZeneca to dissolve biosimilar JV, scrap Rituxan copy program: report

Samsung Biologics, AstraZeneca to dissolve biosimilar JV, scrap Rituxan copy program: report
aliu
Thu, 11/19/2020 – 09:22